Gyre Therapeutics Inc
(GYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,246 | 5,310 | 3,734 | 17,898 | 17,329 |
| Depreciation Amortization | 1,825 | 1,176 | 535 | 1,588 | 1,088 |
| Income taxes - deferred | -1,022 | -491 | -191 | -1,002 | -410 |
| Accounts receivable | -5,981 | -4,966 | -722 | -5,257 | -4,111 |
| Accounts payable and accrued liabilities | 446 | -37 | 14 | -245 | -55 |
| Other Working Capital | -6,088 | -3,635 | -3,346 | -15,688 | -12,067 |
| Other Operating Activity | 6,209 | 4,602 | -153 | -935 | -2,657 |
| Operating Cash Flow | $6,635 | $1,959 | $-129 | $-3,641 | $-883 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -564 | N/A | N/A | -1,686 | -1,686 |
| PPE Investments | -1,027 | -359 | -121 | -1,914 | -2,117 |
| Purchase Of Investment | -11,184 | -11,184 | -8,403 | -15,471 | -14,074 |
| Sale Of Investment | 11,190 | 11,190 | 11,190 | N/A | N/A |
| Purchase Sale Intangibles | -737 | -722 | -699 | -813 | -3 |
| Other Investing Activity | -737 | -722 | -699 | -813 | -3 |
| Investing Cash Flow | $-2,322 | $-1,075 | $1,967 | $-19,884 | $-17,880 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,547 | 25,497 | 1,465 | 2,638 | 1,307 |
| Other Financing Activity | -1,487 | -1,802 | -121 | -536 | -169 |
| Financing Cash Flow | $24,060 | $23,695 | $1,344 | $2,102 | $1,138 |
| Exchange Rate Effect | 216 | 99 | 50 | -273 | -18 |
| Beginning Cash Position | 11,813 | 11,813 | 11,813 | 33,509 | 33,509 |
| End Cash Position | 40,402 | 36,491 | 15,045 | 11,813 | 15,866 |
| Net Cash Flow | $28,589 | $24,678 | $3,232 | $-21,696 | $-17,643 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,635 | 1,959 | -129 | -3,641 | -883 |
| Capital Expenditure | -1,046 | -378 | -122 | -2,315 | -2,380 |
| Free Cash Flow | 5,589 | 1,581 | -251 | -5,956 | -3,263 |